Alexander von Humboldt German International School Montreal

KU Leuven spin-off AstriVax raises € 30 million seed capital to build vaccine platform

Retrieved on: 
Thursday, August 25, 2022

Closing on 30 million, AstriVax has raised the largest amount of seed capital in the history of spin-offs linked to Belgium-based university KU Leuven.

Key Points: 
  • Closing on 30 million, AstriVax has raised the largest amount of seed capital in the history of spin-offs linked to Belgium-based university KU Leuven.
  • Leuven, Belgium, 25 August 2022 Closing on 30 million, AstriVax has raised the largest amount of seed capital in the history of KU Leuven spin-offs.
  • The company will also continue to build its highly innovative, first-in-class plug-and-play vaccine platform based on the ground-breaking work of co-founders Professor Johan Neyts and Kai Dallmeier, PhD, from the KU Leuven Rega Institute.
  • From 2005 to 2021, KU Leuven invested 21.7 million in its spin-off companies, and 1.46 billion of external capital was raised.